Application for Orphan Drug Designation: Borofalan (10B) for Recurrent Malignant Glioma and Recurrent Meningioma
Stella Pharma announces that it has applied to the Japanese Ministry of Health,……
Stella Pharma announces that it has applied to the Japanese Ministry of Health,……
The paper “Efficacy and safety of boron neutron capture therapy for Hypopharyng……
A paper containing the treatment results of unresectable, locally recurrent or ……
Angiosarcoma is a kind of cancer that is derived from vascular endothelial cell……
Business France Japan Office of the French Embassy in Japan engages in building……
On 25th September, the Groundbreaking Ceremony for the Boao BNCT center has tak……
The 66th International Atomic Energy Agency (IAEA) General Conference is being ……
Informa Pharma Intelligence has announced that Stella Pharma is a nominee f……
Japan's public media organization NHK (Japan Broadcasting Corporation) will bro……
Here is a featured story on BNCT (Boron Neutron Capture Therapy) boron drug dev……
The title is “Accelerator-based BNCT for patients with recurrent glioblastoma: ……
The title is "Boron neutron capture therapy using cyclotron-based epithermal ne……